A. Malla

517 total citations
12 papers, 421 citations indexed

About

A. Malla is a scholar working on Psychiatry and Mental health, Social Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, A. Malla has authored 12 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 3 papers in Social Psychology and 3 papers in Experimental and Cognitive Psychology. Recurrent topics in A. Malla's work include Schizophrenia research and treatment (11 papers), Mental Health Treatment and Access (3 papers) and Mental Health Research Topics (3 papers). A. Malla is often cited by papers focused on Schizophrenia research and treatment (11 papers), Mental Health Treatment and Access (3 papers) and Mental Health Research Topics (3 papers). A. Malla collaborates with scholars based in Canada, Venezuela and Ecuador. A. Malla's co-authors include Norbert Schmitz, Ross Norman, Ridha Joober, Rahul Manchanda, Clifford Cassidy, Suzanne King, Laura Béchard‐Evans, Paul Roy, Noori Akhtar‐Danesh and Brian Rush and has published in prestigious journals such as Biological Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

A. Malla

11 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Malla Canada 7 356 139 106 101 41 12 421
Paul D. Meesters Netherlands 13 366 1.0× 118 0.8× 107 1.0× 107 1.1× 24 0.6× 25 462
T.R.E. Barnes United Kingdom 6 287 0.8× 75 0.5× 60 0.6× 63 0.6× 47 1.1× 18 402
R. Conley United States 7 353 1.0× 128 0.9× 60 0.6× 63 0.6× 26 0.6× 11 443
Gema Pardo‐García Spain 12 501 1.4× 141 1.0× 146 1.4× 48 0.5× 46 1.1× 12 596
BJ Kinon United States 6 277 0.8× 70 0.5× 46 0.4× 45 0.4× 36 0.9× 12 344
Lebogang Phahladira South Africa 13 303 0.9× 137 1.0× 71 0.7× 43 0.4× 21 0.5× 39 477
R. Könnecke Germany 5 273 0.8× 108 0.8× 95 0.9× 54 0.5× 14 0.3× 10 367
Manuel Canal‐Rivero Spain 14 236 0.7× 137 1.0× 31 0.3× 37 0.4× 34 0.8× 36 382
Rosa Dueñas Spain 12 330 0.9× 170 1.2× 28 0.3× 30 0.3× 58 1.4× 21 525
György Bartkó Hungary 10 384 1.1× 117 0.8× 177 1.7× 51 0.5× 8 0.2× 17 446

Countries citing papers authored by A. Malla

Since Specialization
Citations

This map shows the geographic impact of A. Malla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Malla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Malla more than expected).

Fields of papers citing papers by A. Malla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Malla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Malla. The network helps show where A. Malla may publish in the future.

Co-authorship network of co-authors of A. Malla

This figure shows the co-authorship network connecting the top 25 collaborators of A. Malla. A scholar is included among the top collaborators of A. Malla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Malla. A. Malla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Cassidy, Clifford, Ross Norman, Rahul Manchanda, Norbert Schmitz, & A. Malla. (2009). Testing Definitions of Symptom Remission in First-Episode Psychosis for Prediction of Functional Outcome at 2 Years. Schizophrenia Bulletin. 36(5). 1001–1008. 95 indexed citations
3.
Klink, Ruby, Ferid Fathalli, Émmanuel Stip, et al.. (2008). Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?. Schizophrenia Research. 102(1-3). 329–336. 84 indexed citations
4.
Béchard‐Evans, Laura, et al.. (2007). Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis☆. Schizophrenia Research. 96(1-3). 206–214. 76 indexed citations
5.
Archie, Suzanne, Brian Rush, Noori Akhtar‐Danesh, et al.. (2006). Substance Use and Abuse in First-Episode Psychosis: Prevalence Before and After Early Intervention. Schizophrenia Bulletin. 33(6). 1354–1363. 83 indexed citations
6.
Smith, Grant J., et al.. (2006). The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology. Acta Psychiatrica Scandinavica. 113(s430). 4–11. 16 indexed citations
7.
Malla, A., et al.. (2006). FC5C UNDERSTANDING THE COMPLEXITIES OF DELAY IN TREATMENT OF PSYCHOSIS AND RELEVANCE FOR EARLY DETECTION INTERVENTIONS. Schizophrenia Research. 86. S40–S40. 6 indexed citations
8.
Archie, Suzanne, et al.. (2006). 0223 SUBSTANCE USE AND ABUSE IN FIRST EPISODE PSYCHOSIS: PREVALENCE BEFORE AND AFTER EARLY INTERVENTION. Schizophrenia Research. 86. S101–S101. 6 indexed citations
9.
Norman, Robert J., A. Malla, Terry McLean, et al.. (2002). An evaluation of a stress management program for individuals with schizophrenia. Schizophrenia Research. 58(2-3). 293–303. 46 indexed citations
10.
Purdon, Scot E., et al.. (2000). 140. Long-term treatment with quetiapine improves cognitive function in schizophrenia. Biological Psychiatry. 47(8). S42–S42. 3 indexed citations
11.
Purdon, Scot E., et al.. (2000). Neuropsychological change in schizophrenia after 6 months of double-blind treatment with quetiapine or haloperidol. Schizophrenia Research. 41(1). 205–206. 5 indexed citations
12.
Malla, A., et al.. (1999). A comparison of long term outcome in first episode schizophrenia patients treated with risperidone or typical antipsychotics. European Neuropsychopharmacology. 9. 297–297. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026